Skip to content
Catalyst

PapersPMID:2493869

Sodium restriction and blood pressure in hypertensive type II diabetics: randomised blind controlled and crossover studies of moderate sodium restriction and sodium supplementation.

BMJ (Clinical research ed.)1989The record ↗

  1. Finding, very limited evidenceraisesSystolic blood pressure

What moved

1 findingHow to read these marks →
  • “In double blind crossover study mean supine systolic blood pressure rose significantly (p less than 0.005) during sodium supplementation (to 171 mm Hg) compared with value after three months of sodium restriction alone (159.9 mm Hg) and after one month of placebo (161.8 mm Hg).”
    Study
    crossover
    Dose studied
    Slow Sodium (sustained release sodium preparation) 80 mmol daily for one month versus matching placebo for one month
    Population
    Nine patients with type II diabetes and mild hypertension in the crossover phase, all continuing moderate dietary sodium restriction in both periods, some on antihypertensive agents other than diuretics; supine blood pressure

Study record

Design
crossover trial / randomised controlled trial
Species
human
Population
Type II diabetics with mild hypertension, diabetic outpatient clinic; crossover phase in nine patients continuing moderate sodium restriction
Participants
34
Comparator
placebo
Duration
91 days
Endpoints measured
8